about
Targeted therapies in sarcomas: challenging the challengeDistinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cellsPAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cellsAberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profilingComparative expressed sequence hybridization to chromosomes for tumor classification and identification of genomic regions of differential gene expressionAn engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogeneFOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma.Bioinformatic analysis of patient-derived ASPS gene expressions and ASPL-TFE3 fusion transcript levels identify potential therapeutic targetsHistone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated stateNovel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumorsUpdate on childhood rhabdomyosarcoma.Protein kinase Cδ promotes proliferation and induces malignant transformation in skeletal muscleNutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell lineChildhood rhabdomyosarcoma: recent advances and prospective views.AKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cellPax genes in embryogenesis and oncogenesis.Protein kinase C iota as a therapeutic target in alveolar rhabdomyosarcoma.A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells.Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein.Imaging findings in noncraniofacial childhood rhabdomyosarcoma.Clinical relevance of molecular genetics to paediatric sarcomasZebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis.Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology GroupmiR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization.Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.RETRACTED: Association of ataxia telangiectasia mutated (ATM) gene mutation/deletion with rhabdomyosarcoma.MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas.Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.18F-FDG microPET imaging detects early transient response to an IGF1R inhibitor in genetically engineered rhabdomyosarcoma models.Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.New insights into the origin and the genetic basis of rhabdomyosarcomas.
P2860
Q21285014-4B7B22C3-0C35-4C96-8019-CF7DD25FB1D4Q24632284-592F7581-A37A-4E64-ABE2-DDBEC020ACD1Q24651250-9B8083D1-0367-45BC-859C-3F495934DEF7Q30563970-E862B9A3-AE8D-42EA-B291-8E7727666ADCQ33930344-0AD29F9F-172E-4277-8017-A898BAED0699Q33964561-8D49E8FC-BA79-4FDA-A15C-CF317C7740E9Q34191937-E266E091-2A57-4E8B-9326-A537CF00C132Q34504946-85717CC6-306F-4A3C-9163-28B5DE23ACA5Q35022234-E57DDE32-2EF3-4156-90D8-6BD952CD60C6Q35070067-44D7AB51-1C9D-4AB0-B7AF-3D7C10FAB0B6Q35090205-0BCAFA7A-A143-4DB3-9051-AF083D4B971AQ35531322-CD045DBE-492A-4615-A0F7-B62BCF1992ECQ35681140-AA40D17B-8C6B-4CDA-B1D4-5EB9D0AE5E89Q35832899-9015DA06-0AED-4673-BFCF-1EAD256A225FQ35847829-FF6BC61B-EE8C-4632-8068-98B2BEA6E833Q35881962-484D2DB8-E9A0-4A48-8F92-60325701DD78Q35886629-FC249E82-6B2E-4781-A5CB-638FD5562A30Q35987724-EFED6097-0418-45CF-8ACB-68BDEB7E6DB6Q36169619-6F635A31-4EDD-4EEB-A972-8CFCC35B7C58Q36403135-536C74A0-FC39-46CE-934A-6236F1F3A43BQ36632585-AEF088EB-1002-404E-9239-AAA72D65E288Q36806186-57678DE5-8C86-4304-B0D2-F4B71B8FD77CQ36975776-F15B9293-C3B4-47D8-A53D-A4BF7885A791Q37071890-57B7F276-34E0-4FE3-AF7F-27A05686CCB2Q37428692-EA6DE56F-CF83-4D1B-89B3-FBAB654615DAQ37587392-AE5B2EC7-7070-4EAE-8057-65E61FEFD735Q38021448-E3CE5A21-61DE-49AA-9BC4-67EA2A1C5FBAQ38355978-33EC3E35-E136-4741-8D81-961A5CC20BA7Q38725853-34B6FAAB-7FE1-4BB1-AD53-DA3507395D2BQ39237435-91D6EC28-9253-4FF4-9BF8-D9F073F51246Q39413508-AEF72395-EB5E-4F68-8EA2-391F10E40203Q42947899-C5D9CEEB-6A5D-42EB-88B4-9B47B558D8B4Q43239032-DE67D497-5F0D-49FA-B5BF-EE7E58F408A8
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Genes, chromosomes, and rhabdomyosarcoma.
@ast
Genes, chromosomes, and rhabdomyosarcoma.
@en
type
label
Genes, chromosomes, and rhabdomyosarcoma.
@ast
Genes, chromosomes, and rhabdomyosarcoma.
@en
prefLabel
Genes, chromosomes, and rhabdomyosarcoma.
@ast
Genes, chromosomes, and rhabdomyosarcoma.
@en
P2093
P1476
Genes, chromosomes, and rhabdomyosarcoma.
@en
P2093
Anderson J
Pritchard-Jones K
P304
P356
10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.3.CO;2-V
P577
1999-12-01T00:00:00Z